Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104M Buy
1,273,050
+78,339
+7% +$5.12M 0.72% 21
2026
Q1
$54.7M Sell
1,194,711
-190,230
-14% -$11M 1.09% 27
2025
Q4
$103M Buy
1,384,941
+1,177,036
+566% +$84.7M 1.26% 19
2025
Q3
$15.2M Sell
207,905
-1,769,977
-89% -$135M 0.3% 48
2025
Q2
$137M Buy
1,977,882
+1,670,429
+543% +$86.6M 3.79% 9
2025
Q1
$13.9M Buy
307,453
+163,247
+113% +$9.67M 0.42% 38
2024
Q4
$8.78M Sell
144,206
-355,652
-71% -$19.8M 0.19% 40
2024
Q3
$20.4M Buy
+499,858
New +$16.6M 0.52% 39

Other funds holding AFRM

Gavin Baker's AFRM Position: Q2 2026 in Review

Gavin Baker increased its Affirm (AFRM) stake by 6.6% in Q2 2026, buying an estimated $5.12M and bringing the position to 1,273,050 shares worth $104M. The position accounts for 0.72% of the portfolio, ranked #21.

Gavin Baker first reported a position in AFRM in Q3 2024 and has held it in 8 quarters since. The position peaked at $137M in Q2 2025. 656 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Gavin Baker held 1,273,050 shares of Affirm worth $104M as of Q2 2026.
  • Gavin Baker bought 78,339 Affirm shares in Q2 2026, an estimated $5.12M.
  • Affirm made up 0.72% of Gavin Baker's portfolio in Q2 2026, its #21 holding.
  • Gavin Baker first reported a position in Affirm in Q3 2024 and has held it in 8 quarters since.
  • Gavin Baker's Affirm position peaked at $137M in Q2 2025.
  • 656 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Atreides Management's 13F filing for Q2 2026, filed 14 Aug 2026.